These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29370710)

  • 1. Detection of glucose metabolism disorders in coronary patients enrolled in cardiac rehabilitation: Is glycated haemoglobin useful? Data from the prospective REHABDIAB study.
    Tatulashvili S; Patois-Vergès B; Nguyen A; Blonde MC; Vergès B
    Eur J Prev Cardiol; 2018 Mar; 25(5):464-471. PubMed ID: 29370710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.
    Bartnik M; Rydén L; Malmberg K; Ohrvik J; Pyörälä K; Standl E; Ferrari R; Simoons M; Soler-Soler J;
    Heart; 2007 Jan; 93(1):72-7. PubMed ID: 16905628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
    Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance of glycated hemoglobin and a risk model for detection of unknown diabetes in coronary patients].
    de la Hera JM; Vegas JM; Hernández E; Lozano I; García-Ruiz JM; Fernández-Cimadevilla OC; Carro A; Avanzas P; Torres F; Bayón J; Menéndez T; Jiménez-Navarro M; Delgado E
    Rev Esp Cardiol; 2011 Sep; 64(9):759-65. PubMed ID: 21752514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk-based prediabetes screening in a rural general practice - oral glucose tolerance test or glycated hemoglobin?].
    Galvács H; Szabó J; Balogh Z
    Orv Hetil; 2019 Dec; 160(50):1976-1983. PubMed ID: 31814420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficacy of screening for diabetes and prediabetes in cardiac rehabilitation after an acute coronary syndrome (ACS). The REHABDIAB study.
    Vergès B; Patois-Vergès B; Goueslard K; Cottenet J; Nguyen A; Tatulashvili S; Blonde MC; Quantin C
    Diabetes Metab; 2019 Jan; 45(1):79-82. PubMed ID: 28669513
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome.
    Bjarnason TA; Hafthorsson SO; Kristinsdottir LB; Oskarsdottir ES; Aspelund T; Sigurdsson S; Gudnason V; Andersen K
    PLoS One; 2017; 12(8):e0183839. PubMed ID: 28854264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of glucose metabolism in patients undergoing coronary artery bypass grafting.
    Greberski K; Guzik P; Wysocki H; Kalawski R
    Kardiol Pol; 2006 Nov; 64(11):1187-93; discussion 1194-5. PubMed ID: 17165159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of oral glucose tolerance test in the acute phase of myocardial infarction.
    Bronisz A; Kozinski M; Magielski P; Fabiszak T; Gierach J; Swiatkiewicz I; Sukiennik A; Kubica A; Bronisz M; Grabczewska Z; Sinkiewicz A; Junik R; Kubica J
    Cardiovasc Diabetol; 2011 Mar; 10():21. PubMed ID: 21396101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey.
    Jackson CA; Yudkin JS; Forrest RD
    Diabetes Res Clin Pract; 1992 Aug; 17(2):111-23. PubMed ID: 1425145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.
    Ferrannini G; De Bacquer D; De Backer G; Kotseva K; Mellbin L; Wood D; Rydén L;
    Diabetes Care; 2020 Apr; 43(4):726-733. PubMed ID: 32079627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The values of the new American Diabetes Association Diagnostic Criteria for screening of pre-diabetes and diabetes in patients undergoing elective coronary angiography].
    Zhao X; Ye Y; Zhang S
    Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):302-6. PubMed ID: 26268057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of glycated haemoglobin in screening for pre-diabetes in Asian Indians--a community survey: the Chandigarh Urban Diabetes Study (CUDS).
    Bhansali A; Walia R; Ravi Kumar P; Ravi Kiran M; Shanmugasundar G
    Diabet Med; 2012 Nov; 29(11):1385-9. PubMed ID: 22414322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study.
    van Valkengoed IG; Vlaar EM; Nierkens V; Middelkoop BJ; Stronks K
    PLoS One; 2015; 10(8):e0136734. PubMed ID: 26317417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HbA1C detection on the diagnostic screening for glucose metabolic disorders in polycystic ovary syndrome.
    Zhen Y; Yang P; Dong R; Wu Y; Sang Y; Du X; Wang Y; Song Q; Yu L; Rao X
    Clin Exp Obstet Gynecol; 2014; 41(1):58-61. PubMed ID: 24707685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.